Torrent Pharmaceuticals Ltd.

₹4,930

0 (0%)

TORNTPHARM Share Price

Pharmaceuticals & Biotechnology

As on September 10, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 1,66,839 Cr

P/E Ratio77.13

Dividend Yield0.15 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	4,918.2	Bullish
10-DMA	4,959	Bearish
20-DMA	4,945.8	Bearish
50-DMA	4,943.95	Bearish
100-DMA	4,674.95	Bullish
200-DMA	4,356.03	Bullish

Historical Performance

1 Year

37.3%

3 Years

163.2%

5 Years

217.2%

10 Years

492.9%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	1,39,797	1,15,161	1,07,278	96,202	85,080
Total Expenditure	96,066	78,117	73,642	67,962	60,768
Other Income	917	399	620	632	1,966
Operating Profit	44,649	37,443	34,256	28,872	26,278
Interest	3,851	2,523	3,536	3,334	2,551
Depreciation	11,189	7,949	8,083	7,066	6,622
Profit Before Tax	28,722	26,728	23,521	18,472	12,259
Consolidated Net Profit	21,634	19,112	16,564	12,452	7,772
Adjusted EPS	64	56	49	37	23

Compounded Sales Growth

10 Years:16

5 Years:11.8

3 Years:7.8

TTM:4

Compounded Profit Growth

10 Years:4.5

5 Years:11.6

3 Years:11.7

TTM:2.5

Stock Price CAGR

10 Years:19.5

5 Years:26

3 Years:38.2

TTM:37.6

Return on Equity

10 Years:27.6

5 Years:23

3 Years:48.9

last year:63.9

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	1,692	1,692	1,692	1,692	846
Total Reserves	82,192	74,215	66,869	60,288	58,683
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	1,76,855	20,877	22,241	28,228	22,381
Other Current Liabilities	24,515	11,435	11,302	15,784	13,651
Short Term Borrowings	29,146	12,500	16,377	17,651	9,230
Total Liabilities	4,36,137	1,43,956	1,45,055	1,44,682	1,26,062
Capital Work in Progress	4,575	3,673	2,808	6,882	5,443
Long Term Loans & Advances	2,813	2,943	3,493	1,810	1,666
Currents Investments	8,657	1,122	1,410	1,561	1,840
Short Term Loans and Advances	7,876	1,996	1,800	1,658	1,512
Total Current Assets	93,919	56,226	56,115	53,137	51,650
Total Assets	4,36,137	1,43,956	1,45,055	1,44,682	1,26,062
Adjusted Book Value	248	224	203	183	176

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 77.13, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 38.2%, indicating sustained price appreciation.
The stock carries a low beta of 0.2, suggesting lower volatility than the broader market.
In the last financial year, the company reported an EBITDA of ₹44649 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹139797 million, indicating a large and established business.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1375711.6

No. of Shares: 279 (Approx)

Performance:37.6%

375711.6

NIFTY Performance: -6.1%

1 day Top Gainers